Home> insulin therapy

SEIZMET G 0.5 Glimepiride (0.5mg), Metformin SR (500mg) SEIZMET G 0.5 is a combination medication used primarily to manage type 2 diabetes mellitus. It combines Glimepiride (0.5mg) and Metformin SR (500mg), offering dual benefits in controlling blood

GLISITAPTIN M KIT Combipack of sitagliptin phosphate (100mg) & Metformin HCI SR (1000mg) GLISITAPTIN M KIT offers a combined therapy solution with Sitagliptin Phosphate (100mg) and Metformin HCl SR (1000mg), ideal for managing type 2 diabetes. This k

GLISAXAPIN M 2.5/500 Saxagliptin (2.5mg), Metformin HCI (ER) (500mg) GLISAXAPIN M 2.5/500 is used to treat type 2 diabetes by combining Saxagliptin (2.5mg) and Metformin HCI (ER) (500mg). Saxagliptin enhances the action of incretin hormones to increa

GLIDAPAFLOZIN M 5/500 Dapagliflozin (5mg), Metformin (500mg) GLIDAPAFLOZIN M 5/500 combines Dapagliflozin and Metformin to treat type 2 diabetes. Dapagliflozin inhibits SGLT2, promoting renal glucose excretion, while Metformin improves insulin sensit

SEIZMET G2 FORTE Glimepiride (2mg), Metformin (1000mg) SEIZMET G2 FORTE is a combination medication containing Glimepiride (2mg) and Metformin (1000mg). It is formulated to manage type 2 diabetes mellitus by targeting different mechanisms to control

GLISAXAPIN 5 Saxagliptin (5mg) GLISAXAPIN 5 is utilized in the treatment of type 2 diabetes mellitus. It is particularly effective when used in combination with diet and exercise to enhance blood sugar control in adults. By inhibiting the DPP-4 enzym

SEIZMET G3 FORTE Glimepiride (3mg), Metformin (1000mg) SEIZMET G3 FORTE is a medication combining Glimepiride (3mg) and Metformin (1000mg) to treat Type 2 Diabetes, ensuring better glycemic control and insulin sensitivity. Uses: This medication is pr

VOGLIGOLD 0.2 Voglibose (0.2mg) VOGLIGOLD 0.2 , containing Voglibose (0.2mg), is an oral anti-diabetic medication. It is designed to help manage postprandial hyperglycemia in patients with type 2 diabetes. By inhibiting the alpha-glucosidase enzyme i